We are live on ! Find out more
BFO

Boston Family Office Portfolio holdings

AUM $1.5B
1-Year Est. Return 11.68%
This Fund
S&P 500
This Quarter Est. Return
+6.37%
1 Year Est. Return
+11.68%
3 Year Est. Return
+44.44%
5 Year Est. Return
+55.04%
10 Year Est. Return
+251.5%
AUM
$813M
AUM Growth
+$43.5M
Cap. Flow
-$1.72M
Cap. Flow %
-0.21%
Top 10 Hldgs %
20.71%
Holding
251
New
10
Increased
63
Reduced
107
Closed
7

Top Buys

Rank Stock Value
1
ADP icon
Automatic Data Processing
ADP
+$2.9M
2
AL
Air Lease Corp
AL
+$2.05M
3
IQV icon
IQVIA
IQV
+$1.92M
4
GOOG icon
Alphabet (Google) Class C
GOOG
+$1.89M
5
GE icon
GE Aerospace
GE
+$1.74M

Top Sells

Rank Stock Value
1
TEVA icon
Teva Pharmaceuticals
TEVA
+$2.64M
2
MIDD icon
Middleby
MIDD
+$2.44M
3
GILD icon
Gilead Sciences
GILD
+$1.58M
4
ROK icon
Rockwell Automation
ROK
+$1.34M
5
AAPL icon
Apple
AAPL
+$1.04M

Sector Composition

Rank Sector Weight
1 Healthcare 17.01%
2 Industrials 14.02%
3 Technology 13.29%
4 Consumer Staples 10.45%
5 Financials 7.83%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
WAB icon
51
Wabtec
WAB
$50.5B
$5.33M 0.66%
68,316
-14
-0% -$1.16K
NEE icon
52
NextEra Energy
NEE
$182B
$5.3M 0.65%
165,072
+2,300
+1% +$72.3K
GLNG icon
53
Golar LNG
GLNG
$5.03B
$5.2M 0.64%
186,166
-12,211
-6% -$326K
ROP icon
54
Roper Technologies
ROP
$38.8B
$5.06M 0.62%
24,510
-330
-1% -$66.2K
LKQ icon
55
LKQ Corp
LKQ
$6.2B
$5.03M 0.62%
171,849
+5,910
+4% +$184K
DHR icon
56
Danaher
DHR
$137B
$4.86M 0.6%
64,134
+709
+1% +$52.8K
ABT icon
57
Abbott
ABT
$182B
$4.86M 0.6%
109,444
+4,698
+4% +$203K
MO icon
58
Altria Group
MO
$114B
$4.75M 0.58%
66,561
– –
XRAY icon
59
Dentsply Sirona
XRAY
$2.86B
$4.66M 0.57%
74,675
-1,980
-3% -$119K
V icon
60
Visa
V
$690B
$4.61M 0.57%
51,818
+3,130
+6% +$269K
IBM icon
61
IBM
IBM
$222B
$4.52M 0.56%
27,144
-115
-0.4% -$19.3K
CSCO icon
62
Cisco
CSCO
$480B
$4.33M 0.53%
128,252
-20,405
-14% -$662K
CVX icon
63
Chevron
CVX
$379B
$4.19M 0.52%
39,041
+3,380
+9% +$379K
PFE icon
64
Pfizer
PFE
$145B
$4.19M 0.51%
128,993
-25,891
-17% -$816K
EEM icon
65
iShares MSCI Emerging Markets ETF
EEM
$29.7B
$4.16M 0.51%
105,685
+650
+0.6% +$24.7K
CL icon
66
Colgate-Palmolive
CL
$73.8B
$4.11M 0.5%
56,083
-380
-0.7% -$26.6K
LECO icon
67
Lincoln Electric
LECO
$15.1B
$4.06M 0.5%
46,726
-2,619
-5% -$220K
KO icon
68
Coca-Cola
KO
$372B
$3.85M 0.47%
90,722
-950
-1% -$39.6K
SPGI icon
69
S&P Global
SPGI
$122B
$3.82M 0.47%
29,225
-450
-2% -$55.9K
LOW icon
70
Lowe's Companies
LOW
$122B
$3.82M 0.47%
46,444
-2,750
-6% -$210K
INTC icon
71
Intel
INTC
$509B
$3.71M 0.46%
102,934
-1,260
-1% -$45.6K
THO icon
72
Thor Industries
THO
$4.16B
$3.56M 0.44%
37,032
+560
+2% +$58.1K
CLX icon
73
Clorox
CLX
$12.7B
$3.47M 0.43%
25,759
+5,345
+26% +$692K
VZ icon
74
Verizon
VZ
$195B
$3.4M 0.42%
69,844
-454
-0.6% -$22.8K
TEL icon
75
TE Connectivity
TEL
$62.9B
$3.35M 0.41%
44,909
+6,420
+17% +$472K
1 2
3
4 5

Similar funds

CP
Caligan Partners New York $1.5B AUM 518.95% 1-Year Est. Return
JFGLC
Johnson Financial Group LLC (Colorado) Denver, Colorado $1.5B AUM 16.09% 1-Year Est. Return
AAM
Aureus Asset Management Boston, Massachusetts $1.5B AUM 20.3% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.5B AUM 19.72% 1-Year Est. Return
SCM
SG Capital Management Chicago, Illinois $1.51B AUM 49.98% 1-Year Est. Return
FMI
F/M Investments Washington, District of Columbia $1.51B AUM 25.86% 1-Year Est. Return
NSGL
No Street GP LP San Francisco, California $1.5B AUM 34.53% 1-Year Est. Return
RCW
Rheos Capital Works Tokyo, Japan $1.5B AUM 47.78% 1-Year Est. Return

Boston Family Office's Q1 2017 Portfolio in Review

As of Q1 2017, Boston Family Office held 251 positions worth $813M, up 5.6% from $770M the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Boston Family Office's Q1 2017 filing shows 10 new, 63 increased, 107 reduced and 7 closed positions. Its largest new stake was Teradyne: 22,100 shares worth $687K. The largest sale was Teva Pharmaceuticals, an estimated $2.64M.

By sector, the portfolio is most concentrated in Healthcare at 17% of assets, down from 17% a quarter earlier, followed by Industrials and Technology.

  • Boston Family Office's largest Q1 2017 buy was Teradyne: 22,100 shares worth $687K.
  • Boston Family Office added most to Automatic Data Processing in Q1 2017, an estimated $2.9M increase.
  • Boston Family Office's biggest Q1 2017 reduction was Middleby, cutting an estimated $2.44M.
  • Boston Family Office fully exited Teva Pharmaceuticals in Q1 2017, selling an estimated $2.64M.
  • Boston Family Office's ten largest holdings make up 21% of its $813M portfolio in Q1 2017.
  • Boston Family Office opened 10 new positions and closed 7 in Q1 2017.
  • Boston Family Office's portfolio value rose 5.6% quarter-over-quarter to $813M.

Based on Boston Family Office's 13F filing for Q1 2017, filed 5 May 2017.